Abstract
Aim:
To investigate the anticancer activity of dihydroartemisinin (DHA), a derivative of antimalaria drug artemisinin in a panel of human ovarian cancer cell lines.
Methods:
Cell growth was determined by the MTT viability assay. Apoptosis and cell cycle progression were evaluated by a DNA fragmentation gel electro-phoresis, flow cytometry assay, and TUNEL assay; protein and mRNA expression were analyzed by Western blotting and RT-PCR assay.
Results:
Artemisinin and its derivatives, including artesunate, arteether, artemether, arteannuin, and DHA, exhibit anticancer growth activities in human ovarian cancer cells. Among them, DHA is the most effective in inhibiting cell growth. Ovarian cancer cell lines are more sensitive (5-10-fold) to DHA treatment compared to normal ovarian cell lines. DHA at micromolar dose levels exhibits a dose- and time-dependent cytotoxicity in ovarian cancer cell lines. Furthermore, DHA induced apoptosis and G2 cell cycle arrest, accompanied by a decrease of Bcl-XL and Bcl-2 and an increase of Bax and Bad.
Conclusion:
The promising results show for the first time that DHA inhibits the growth of human ovarian cancer cells. The selective inhibition of ovarian cancer cell growth, apoptosis induction, and G2 arrest provide in vitro evidence for further studies of DHA as a possible anticancer drug in the clinical treatment of ovarian cancer.
Similar content being viewed by others
Article PDF
References
Tewari KS, Mehta RS, Burger RA, Yu IR, Kyshtoobayeva AS, Monk BJ, et al. Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma. Gynecol Oncol 2005; 98: 360–8.
Skirnisdottir I, Garmo H, Holmberg L . Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer. Gynecol Oncol 2007; 105: 166–71.
Tan DS, Agarwal R, Kaye SB . Mechanisms of transcoelomic metastasis in ovarian cancer, Lancet Oncol 2006; 7: 925–34.
Nam W, Tak J, Ryu JK, Jung M, Yook JI, Kim HJ, et al. Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. Head Neck 2007; 29: 335–40.
Dell'Eva R, Pfeffer U, Vene R, Anfosso L, Forlani A, Albini A, et al. Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochem Pharmacol 2004; 68: 2359–66.
Lee J, Zhou HJ, Wu XH . Artemisinin induces apoptosis in human cancer cells. Anticancer Res 2004; 24: 2277–80.
Singh NP, Lai H . Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer Cells. Life Sci 2001; 70: 49–56.
Efferth T, Olbrich A, Bauer R . mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, afrteether, and artemether. Biochem Pharmacol 2002; 64: 617–23.
Yamachika E, Habte T, Oda D . Artemisinin: an alternative treatment for oral squamous cell carcinoma. Anticancer Res 2004; 24: 2153–60.
Chen HH, Zhou HJ, Fang X . Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro, Pharmacol Res 2003; 48: 231–6.
Xie B, Ling JJ . Anti-tumor activity of artemisinin and its derivatives. J Guangzhou Univ TRadit Chin Med 2005; 22: 75–7. Chinese.
Liu X . Studies on artemisinin and its derivatives. Guangxi Med J 2003; 25: 1950–9. Chinese.
Sun WC, Han JX, Yang WY . The in vitro anti-tumor effect of four artemisinic acid and artesunate B derivatives. Acta Pharmacol Sin 1992; 13: 541–3. Chinese.
Yang XP, Pan QC, Liang YJ . The anti-tumor activity of sodium artesunate. Chin J Cancer 1997; 16: 186–9. Chinese.
Lin F, Qian ZY, Xue HW, Ding J, Lin LP . Comparison of inhibitory effects between artemisinin and artemisunate on proliferation of MCF-7 cells in vitro. Chin Tradit Herb Drugs 2003; 4: 347–9. Chinese.
Zhang JX, Wang SX, Zhang FG, Zhang YH . Primary study of effect of hypoxic killing and radiation sensitivity of artemisinin on human cervical cancer cell. Chin J Cancer 2001; 20: 1363–6. Chinese.
Dong HY, Wang ZF, Song WH, Wanfg L, Yang BF . Apoptosis induced by artermisinin in K562 cells. Bull Chin Cancer 2003; 12: 473–5. Chinese.
Yang XP, Zhang X . Induction of human tumor cell apoptosis by sodium artesunate and its molecular mechanism. Chin Tradit Herb Drugs 2002; 33: 819–21. Chinese.
Wang Q, Wu LM, Zhao Y, Zhang XL, Wang NP . The anticancer effect of artesunate and its mechanism. Acta Pharm Sin 2002; 37: 477–8. Chinese.
Lin F, Qian ZY, Ding J, Lin LP . Effect of dihydroartemisinin on the proliferation of MCF-7 cell. Chin J New Drugs 2002; 11: 934–6. Chinese.
Zhou J, Meng R, Li LM, Liu Y, Li BX, Yang BF . In vitro effect of artemisinin on human leukemia cells and primary cells. Chin J Intern Med 2003; 42: 713–4. Chinese.
Posner GH, McRiner AJ, Paik IH . Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents. J Med Chem 2004; 47: 1299–302.
Efferth T . Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Curr Drug Targets 2006; 7: 407–21.
Golenser J, Waknine JH, Krugliak M, Hunt NH, Grau GE . Current perspectives on the mechanism of action of artemisinins. Int J Parasitol 2006; 36: 1427–41.
Kim SJ, Kim MS, Lee JW, Lee CH, Yoo H, Shin SH, et al. Dihydroartemisinin enhances radiosensitivity of human glioma cells In vitro. J Cancer Res Clin Oncol 2006; 132: 129–35.
Jung M, Tak J, Chung WY, Park KK . Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane. Bioorg Med Chem Lett 2006; 16: 1227–30.
Fan S, Ma YX, Gao M, Yaun RQ, Ment Q, Goldberg ID, et al. The multisubstrate adapter Gabl regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair. Mol Cell Biol 2001; 21: 4968–84.
Fan S, Gao M, Meng Q, Laterra JJ, Symons MH, Coniglio S, et al. Role of NF-KappaB signaling in heptocyte growth factor/scatter factor-mediated cell protection. Oncogene 2005; 24: 1749–66.
Vogelstein B, Lane D, Levine AJ . Surfing the p53 network. Nature 2000; 408: 307–10.
Fan S, El-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, et al. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 1994; 54: 5824–30.
El-Deiry WS . The role of p53 in chemosensitivity and radiosensitivity. Oncogene 2003; 22: 7486–95.
Cuddihy AR, Bristow RG . The p 53 protein family and radiation sensitivity: Yes or no? Cancer Metastasis Rev 2004; 23: 237–57.
Levine AJ . p53, the cellular gatekeeper for growth and divison. Cell 1997; 88: 323–31.
Levine AJ, Momand J, Finlay CA . The p53 tumour suppressor gene. Nature 1991; 351: 453–6.
Bremer E, van Dam G, Kroesen BJ, de Leij L, Helfrich W . Targeted induction of apoptosis for cancer therapy: current progress and prospects. Trends Mol Med 2006; 12: 382–93.
Isoldi MC, Visconti MA, Castrucci AM . Anti-cancer drugs: molecular mechanisms of action. Mini Rev Med Chem 2005; 5: 685–95.
Walensky LD . BCL-2 in the crosshairs: tipping the balance of life and death. Cell Death Differ 2006; 13: 1339–50.
Adams JM, Cory S . Life-or-death decisions by the Bcl-2 protein familoy. Trends Biochem Sci 2001; 26: 61–6.
Thomadaki H, Socrilas A . BCL2 familoy of apoptosis-related genes: functions and clinical implications in cancer. Crit Rev Clin Lab Sci 2006; 43: 1–67.
Kim R . Recent advances in understanding the celll death pathways activated by anticancer therapy. Cancer 2005; 103: 1551–60.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by grants from the National Natural Science Foundation of China (No 30128018), the Natural Science Foundation of Jiangsu Province (No 03KJA180121), the Medical Development Foundation of Soo-chow University (No EE126506), and USA NIH (No ES013199).
Rights and permissions
About this article
Cite this article
Jiao, Y., Ge, Cm., Meng, Qh. et al. Dihydroartemisinin is an inhibitor of ovarian cancer cell growth. Acta Pharmacol Sin 28, 1045–1056 (2007). https://doi.org/10.1111/j.1745-7254.2007.00612.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00612.x
Keywords
This article is cited by
-
Metal-organic framework-encapsulated dihydroartemisinin nanoparticles induces apoptotic cell death in ovarian cancer by blocking ROMO1-mediated ROS production
Journal of Nanobiotechnology (2023)
-
Oligomers of carrageenan regulate functional activities and artemisinin production in Artemisia annua L. exposed to arsenic stress
Protoplasma (2020)
-
Artemisinin and its derivatives: a promising cancer therapy
Molecular Biology Reports (2020)
-
A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies
Cancer Chemotherapy and Pharmacology (2018)
-
Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives
Cancer Chemotherapy and Pharmacology (2017)